Posted

Boston goes hand-in-hand with the Massachusetts Institute of Technology and Harvard, big name universities linked to the people behind everything from Arpanet to Facebook. Indeed, MIT helped to make the term technology part of our modern lexicon. But while Boston may have a reputation as a powerhouse incubator for computing, the city and neighboring Cambridge are also generating traction as a biotech and pharma hub. Today the Boston Metro area is home to the largest concentration of biopharma activity in the… Read more »

Posted

By Angela Woodall, Healthcare and Environmental Reporter. Many of us will remember the Facebook images of celebrities submitting to the shock of icy water poured over them to raise money for ALS research. Apart from its obvious viral quality on social media, the icy water was intended to simulate the sensation so that those who take part can experience one of the symptoms of ALS (to a much milder and very temporary extent). This year the ice has been replaced a… Read more »

Posted

By Angela Woodall, Healthcare and Environmental Reporter. Parkinson’s disease was first diagnosed two centuries ago. Today it ranks among the most common degenerative disorders. However, a resolution is stubbornly elusive, as is the case with many diseases of the central nervous system despite a multitude of clinical trials. Patients and advocates are keenly aware of the figures as well as the pace of treatments coming to market. The last breakthrough treatment, Rytary, was a reformulation of an existing dopamine replacement… Read more »

Posted

By Angela Woodall, Healthcare and Environmental Reporter. The old image of orthopedics is an outdated one. While the field still deals with broken bones, strained muscles and torn ligaments. the way that these orthopedic injuries are being treated has evolved dramatically. New techniques are providing new methods that complement traditional approaches -­from 3-D printing to stem cell therapies that help prevent surgery and robotics for orthopedic rehabilita­tion . Computing is a significant contribution but helping to spur the new wave… Read more »

Posted

By Angela Woodall, Healthcare and Environmental Reporter.   Looking back at 2017, a year of change in leadership, legislation, investment and innovation at almost every level, two events stand out. The first is the 21st Century Cures Act, a jumbo spending package that began rolling out this year. The second is the 2017 reauthorization of the User Fees Act, a funding lifeline to the FDA. Not only did the two acts inject millions into the industry, but each influenced the… Read more »

Posted

By Angela Woodall, Healthcare and Environmental Reporter. In 2015, several pharmaceutical manufacturing companies inside and outside the United States received a warning from the U.S. Food and Drug Administration that their manufacturing standards were deviating from good practices. Some problems related to data controls, others to anti-contamination procedures. Enforcement of the standards, known as CGMP, is one of the multiple roles required of the FDA and one that may see a sharpening of focus as the result of the agency’s… Read more »

Posted

Clinpulse is an ongoing series of expert panel discussions on topics related to the advancement of clinical research. Our event on Sept 21st, 2017 in Boston brought together industry experts to discuss patient enrollment strategies. Melissa Price VP, Clinical Development, TARIS Biomedical Roger D. Nolan, Ph.D Co-Founder, President and COO, Biokier Carole Ann McEvoy Clinical Study Manager, PRC Clinical Faith Kolb VP, Biometric Operations, SDC Bryce Warren, Ph.D Executive Consultant in Clinical Operations   Introduction at ClinPulse Boston   Working… Read more »

Posted

By Angela Woodall, Healthcare and Environmental Reporter. Despite decades of focused research, treatments for neurology-related disorders are limited. However, recent work promises to widen the window on options. Several avenues of investigation have raised hopes that research will finally begin to cross the chasm between bench and bedside by developing treatments for the millions of people afflicted by debilitating disorders like Parkinson’s, Huntington’s, ALS and stroke. In the offing in 2017 is a multiplicity of breakthroughs, including the first Food… Read more »